Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and a USD 45 million … Continued
—Oxford Finance Debt Facility for up to $125 Million— —Series B Warrants Will Expire in 75 Days, and if Fully Exercised, Could Provide An Additional $33.3 Million— SAN MATEO, Calif.–(BUSINESS … Continued
$1.4BN+ in New Capital Commitments 20 New Platform Transactions 7 Upsizes with Existing Borrowers ALEXANDRIA, Va. –(BUSINESS WIRE)– Oxford Finance LLC (“Oxford”) is a leading provider of capital for … Continued
Choice Health at Home, LLC (“Choice”), the Texas-based provider of home health, hospice, and rehabilitation services, announced today the closing of a new $190 million credit facility led by Oxford Finance … Continued
Kezar is a biopharmaceutical company committed to developing breakthrough treatments for immune-mediated and oncologic disorders. ALEXANDRIA, Va. & SOUTH SAN FRANCISCO, Calif. –(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides … Continued
PlateletBio is pioneering an entirely new platform of cell-based therapeutics based on platelet biology ALEXANDRIA, Va. & WATERTOWN, Mass. –(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm that … Continued
